Company Filing History:
1 out of 20 
1 out of 2 Years Active: 2015
Title: Martina Schweiger: Innovator in Pharmaceutical Composition
Introduction
Martina Schweiger is a notable inventor based in Graz, Austria. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address serious health conditions. Her work focuses on innovative solutions for disorders such as cachexia, stroke, atherosclerosis, coronary artery disease, and diabetes.
Latest Patents
Martina Schweiger holds a patent for a compound known as ATGListatin, along with a pharmaceutical composition comprising the same. This compound is defined by a specific formula and is useful in the treatment and prevention of various disorders. The patent also outlines a method for screening lipase inhibitors using this compound, which includes in vitro assays and cellular assays to determine its lipase inhibitory activity. Furthermore, the patent describes methods for treating or preventing conditions involving cachexia, stroke, atherosclerosis, coronary artery disease, and diabetes, particularly type II diabetes, by administering a pharmaceutical composition that inhibits ATGL.
Career Highlights
Throughout her career, Martina has been associated with prestigious institutions such as Technische Universität Graz and Karl-Franzens-Universität Graz. Her academic and research endeavors have significantly contributed to her expertise in pharmaceutical innovations.
Collaborations
Martina has collaborated with notable colleagues, including Matthias Romauch and Robert Zimmermann. These partnerships have enhanced her research and development efforts in the pharmaceutical field.
Conclusion
Martina Schweiger is a pioneering inventor whose work in pharmaceutical compositions has the potential to impact the treatment of various serious health conditions. Her innovative approach and dedication to research continue to inspire advancements in the field.